302 related articles for article (PubMed ID: 32353594)
1. Results of polidocanol endovenous microfoam in clinical practice.
Kim PS; Elias S; Gasparis A; Labropoulos N
J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):122-127. PubMed ID: 32353594
[TBL] [Abstract][Full Text] [Related]
2. Endovenous microfoam ablation of below knee superficial truncal veins is safe and effective in patients with prior saphenous treatment across a wide range of CEAP classes.
Jimenez JC; Lawrence PF; Pavlyha M; Farley SM; Rigberg DA; DeRubertis BG; Woo K;
J Vasc Surg Venous Lymphat Disord; 2022 Mar; 10(2):390-394. PubMed ID: 34474174
[TBL] [Abstract][Full Text] [Related]
3. Use of Polidocanol Endovenous Microfoam to Improve Hemodynamics and Symptomology in Patients with Challenging Clinical Presentations: A Case Series.
Davis PE; Phillips J; Kolluri R
Ann Vasc Surg; 2018 Oct; 52():176-182. PubMed ID: 29772321
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive techniques to minimize thrombotic complications following microfoam sclerotherapy of saphenous trunks and tributaries.
Jimenez JC; Lawrence PF; Woo K; Chun TT; Farley SM; Rigberg DA; Baril DT; Derubertis BG
J Vasc Surg Venous Lymphat Disord; 2021 Jul; 9(4):904-909. PubMed ID: 33248297
[TBL] [Abstract][Full Text] [Related]
5. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.
Todd KL; Wright DI;
Phlebology; 2014 Oct; 29(9):608-18. PubMed ID: 23864535
[TBL] [Abstract][Full Text] [Related]
6. Treatment of superficial venous insufficiency in a large patient cohort with retrograde administration of ultrasound-guided polidocanol endovenous microfoam versus endovenous laser ablation.
Deak ST
J Vasc Surg Venous Lymphat Disord; 2022 Sep; 10(5):999-1006.e2. PubMed ID: 34958977
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Truncal Incompetence and Varicose Veins with a Single Administration of a New Polidocanol Endovenous Microfoam Preparation Improves Symptoms and Appearance.
King JT; O'Byrne M; Vasquez M; Wright D;
Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):784-93. PubMed ID: 26384639
[TBL] [Abstract][Full Text] [Related]
8. Comparison of outcomes following polidocanol microfoam and radiofrequency ablation of incompetent thigh great and accessory saphenous veins.
Talutis SD; Chin AL; Lawrence PF; Woo K; Jimenez JC
J Vasc Surg Venous Lymphat Disord; 2023 Sep; 11(5):916-920. PubMed ID: 37030446
[TBL] [Abstract][Full Text] [Related]
9. An Italian experience with mechanochemical ablation of the saphenous vein since 2012.
Mirandola M; Griso A; Migliara B; Cappellari TF; Giovannini F; Lino M
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):999-1005. PubMed ID: 32179039
[TBL] [Abstract][Full Text] [Related]
10. A multicenter, randomized, placebo-controlled trial of endovenous thermal ablation with or without polidocanol endovenous microfoam treatment in patients with great saphenous vein incompetence and visible varicosities.
Vasquez M; Gasparis AP;
Phlebology; 2017 May; 32(4):272-281. PubMed ID: 26957489
[TBL] [Abstract][Full Text] [Related]
11. Endovenous laser and echo-guided foam ablation in great saphenous vein reflux: one-year follow-up results.
Gonzalez-Zeh R; Armisen R; Barahona S
J Vasc Surg; 2008 Oct; 48(4):940-6. PubMed ID: 18639418
[TBL] [Abstract][Full Text] [Related]
12. Experience with concomitant ultrasound-guided foam sclerotherapy and endovenous laser treatment in chronic venous disorder and its influence on Health Related Quality of Life: interim analysis of more than 1000 consecutive procedures.
King T; Coulomb G; Goldman A; Sheen V; McWilliams S; Guptan RC
Int Angiol; 2009 Aug; 28(4):289-97. PubMed ID: 19648872
[TBL] [Abstract][Full Text] [Related]
13. Retrograde administration of ultrasound-guided endovenous microfoam chemical ablation for the treatment of superficial venous insufficiency.
Deak ST
J Vasc Surg Venous Lymphat Disord; 2018 Jul; 6(4):477-484. PubMed ID: 29909854
[TBL] [Abstract][Full Text] [Related]
14. Early results of mechanochemical ablation for small saphenous vein incompetency using 2% polidocanol.
Baccellieri D; Apruzzi L; Ardita V; Favia N; Saracino C; Carta N; Melissano G; Chiesa R
J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):683-690. PubMed ID: 32916372
[TBL] [Abstract][Full Text] [Related]
15. Prospective randomized trial of antithrombotic strategies following great saphenous vein ablation using injectable polidocanol endovenous microfoam (Varithena).
Yang J; Chung S; Srivatsa S
J Vasc Surg Venous Lymphat Disord; 2023 May; 11(3):488-497.e4. PubMed ID: 36592692
[TBL] [Abstract][Full Text] [Related]
16. Clinical response to combination therapy in the treatment of varicose veins.
Conway RG; Almeida JI; Kabnick L; Wakefield TW; Buchwald AG; Lal BK
J Vasc Surg Venous Lymphat Disord; 2020 Mar; 8(2):216-223. PubMed ID: 31843482
[TBL] [Abstract][Full Text] [Related]
17. Increased body mass index and vein diameter are associated with incomplete target vein closure following microfoam ablation of incompetent saphenous veins.
Talutis SD; Chin AL; Lawrence PF; Woo K; Farley SM; Duong W; Jimenez JC
J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101690. PubMed ID: 37788744
[TBL] [Abstract][Full Text] [Related]
18. A multicenter, randomized, placebo-controlled study to evaluate the efficacy and safety of Varithena® (polidocanol endovenous microfoam 1%) for symptomatic, visible varicose veins with saphenofemoral junction incompetence.
Gibson K; Kabnick L;
Phlebology; 2017 Apr; 32(3):185-193. PubMed ID: 27013511
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial to evaluate the safety and efficacy of transluminal injection of foam sclerotherapy compared with ultrasound-guided foam sclerotherapy during endovenous catheter ablation in patients with varicose veins.
Watanabe S; Okamura A; Iwamoto M; Nagai H; Sumiyoshi A; Tanaka K; Suzuki S; Tanaka H; Iwakura K; Fujii K
J Vasc Surg Venous Lymphat Disord; 2022 Jan; 10(1):75-81.e1. PubMed ID: 34252576
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
Rabe E; Otto J; Schliephake D; Pannier F
Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
